Header Logo

Connection

MICHAEL A DAVIES to CD8 Antigens

Back to Details
This is a "connection" page, showing publications MICHAEL A DAVIES has written about CD8 Antigens.
MICHAEL A DAVIES
Connection Strength
0.033
CD8 Antigens
  1. Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial. JAMA Oncol. 2016 Aug 01; 2(8):1056-64.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.